[
  {
    "ts": "2026-02-11T03:07:17+00:00",
    "headline": "Quest Diagnostics Q4 Earnings Call Highlights",
    "summary": "Quest Diagnostics (NYSE:DGX) executives highlighted what they described as strong execution in 2025 and outlined expectations for continued organic growth in 2026, while also discussing a one-year delay in PAMA rate cuts, the ramp of major partnerships, and ongoing investment in operational moderniz",
    "url": "https://www.marketbeat.com/instant-alerts/quest-diagnostics-q4-earnings-call-highlights-2026-02-10/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "f1b00126-cd8a-3222-b49d-cf742161d398",
      "content": {
        "id": "f1b00126-cd8a-3222-b49d-cf742161d398",
        "contentType": "STORY",
        "title": "Quest Diagnostics Q4 Earnings Call Highlights",
        "description": "",
        "summary": "Quest Diagnostics (NYSE:DGX) executives highlighted what they described as strong execution in 2025 and outlined expectations for continued organic growth in 2026, while also discussing a one-year delay in PAMA rate cuts, the ramp of major partnerships, and ongoing investment in operational moderniz",
        "pubDate": "2026-02-11T03:07:17Z",
        "displayTime": "2026-02-11T03:07:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/6e634b263530c7377a955f9cf2ccc57b",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Quest Diagnostics logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HnfdYrsMfltF9venlpWqzw--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/6e634b263530c7377a955f9cf2ccc57b.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nUiC7g7uH0nLv4dd7DQdzg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/6e634b263530c7377a955f9cf2ccc57b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/quest-diagnostics-q4-earnings-call-highlights-2026-02-10/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-q4-earnings-call-030717648.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            },
            {
              "symbol": "FSNUF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T05:32:23+00:00",
    "headline": "DGX Q4 Deep Dive: Consumer Testing and Advanced Diagnostics Fuel Growth Amid Margin Headwinds",
    "summary": "Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 7.1% year on year to $2.81 billion. The company’s full-year revenue guidance of $11.76 billion at the midpoint came in 3.3% above analysts’ estimates. Its non-GAAP profit of $2.42 per share was 2.6% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/dgx-q4-deep-dive-consumer-053223672.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "c5b50a68-3610-3887-a771-48b7824a2017",
      "content": {
        "id": "c5b50a68-3610-3887-a771-48b7824a2017",
        "contentType": "STORY",
        "title": "DGX Q4 Deep Dive: Consumer Testing and Advanced Diagnostics Fuel Growth Amid Margin Headwinds",
        "description": "",
        "summary": "Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 7.1% year on year to $2.81 billion. The company’s full-year revenue guidance of $11.76 billion at the midpoint came in 3.3% above analysts’ estimates. Its non-GAAP profit of $2.42 per share was 2.6% above analysts’ consensus estimates.",
        "pubDate": "2026-02-11T05:32:23Z",
        "displayTime": "2026-02-11T05:32:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/a002c113304d0049242cefeebcf6d343",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "DGX Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aeh65E_EG08O8chSqy1MVw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/a002c113304d0049242cefeebcf6d343.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l7C10YsggYCA0fc.htm8Ww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/a002c113304d0049242cefeebcf6d343.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/dgx-q4-deep-dive-consumer-053223672.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dgx-q4-deep-dive-consumer-053223672.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T14:15:03+00:00",
    "headline": "Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue?",
    "summary": "Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
    "url": "https://finance.yahoo.com/news/quest-diagnostics-incorporated-dgx-hit-141503062.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "5a88bb91-8434-3e69-98c7-cd5066cc9f80",
      "content": {
        "id": "5a88bb91-8434-3e69-98c7-cd5066cc9f80",
        "contentType": "STORY",
        "title": "Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue?",
        "description": "",
        "summary": "Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
        "pubDate": "2026-02-11T14:15:03Z",
        "displayTime": "2026-02-11T14:15:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/670d1917693293f70179651625deb88f",
          "originalWidth": 900,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/T5hbaObWi1jST2y00rKbhQ--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/670d1917693293f70179651625deb88f.cf.webp",
              "width": 900,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Oc5UMRa8ji_BfGLG4u5KZw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/670d1917693293f70179651625deb88f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-incorporated-dgx-hit-141503062.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-incorporated-dgx-hit-141503062.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            },
            {
              "symbol": "DVA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]